L

Leading HIV research

We bring new solutions and facilitate progress towards curing and eradicating HIV/AIDS

Read more
Y

Your support means a lot

Donate to IrsiCaixa and benefit from tax relief

Read more
P

Promote your career with us

Find out about our training programs and job offers

Read more

Home

The immune system, the focus of our research

The knowledge generated around the immune system allows IrsiCaixa to work in 6 main research areas.

Imatge malalties infeccioses

Global infectious diseases

HIV/AIDS
SARS-CoV-2

Imatge de malalties emergents

Emerging infectious diseases

Imatge de immunopatologia de les malalties

Immunopathology

Immunosenescence
Neuroimmunology

Imatge de Microbioma

Microbiome

Imatge de càncer

Cancer

Imatge de Teràpies

Therapies and vaccines

Our numbers

Impact Factor: 1027
H Index: 102

+1400

publications

National: 71
International: 32

114

active projects

12 research groups

120

Professionals

with cum laude grade

70

theses

generating knowledge of the immune system

26

years of experience

46 institutions

13

partner countries

Bonaventura Clotet Director IrsiCaixa

The road we have traveled since 1981 in HIV research has allowed us to pave other roads and keep taking solid steps against infectious diseases.

Dr. Bonaventura Clotet

IrsiCaixa director

Latest news

HIV

Vaccines

03/05/2023

IrsiCaixa designs HIV-like particles that induce an effective immune response in preclinical studies
HIV

13/04/2023

New insights on the early stages of HIV infection in the human body
SARS-CoV-2

Vaccines

31/03/2023

HIPRA's COVID-19 vaccine, developed with the scientific support of IrsiCaixa, receives a positive opinion from the European Medicines Agency

Promoted by

Recognized by

Centre of

In cooperation with

HIPRA

Fundacio Gloria Soler